BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35484888)

  • 21. Promoter Hypermethylation of the Eyes Absent 4 Gene is a Tumor-Specific Epigenetic Biomarker in Iranian Colorectal Cancer Patients.
    Barati Bagerabad M; Tavakolian S; Abbaszadegan MR; Kerachian MA
    Acta Med Iran; 2018 Jan; 56(1):21-27. PubMed ID: 29436791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers.
    Orjuela S; Menigatti M; Schraml P; Kambakamba P; Robinson MD; Marra G
    BMC Cancer; 2020 Apr; 20(1):290. PubMed ID: 32252665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.
    To KK; Leung WW; Ng SS
    Mol Carcinog; 2017 Feb; 56(2):464-477. PubMed ID: 27253631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer.
    Li X; Cai D; Huang Y; Xie Y; Shen D; Yuan Z; Liu X; Huang M; Luo Y; Yu H; Wang X
    BMC Cancer; 2023 Apr; 23(1):315. PubMed ID: 37020199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LINE-1 hypomethylation is not a common event in preneoplastic stages of gastric carcinogenesis.
    Kupcinskas J; Steponaitiene R; Langner C; Smailyte G; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
    Sci Rep; 2017 Jul; 7(1):4828. PubMed ID: 28684753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues.
    Simmer F; Brinkman AB; Assenov Y; Matarese F; Kaan A; Sabatino L; Villanueva A; Huertas D; Esteller M; Lengauer T; Bock C; Colantuoni V; Altucci L; Stunnenberg HG
    Epigenetics; 2012 Dec; 7(12):1355-67. PubMed ID: 23079744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
    Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
    BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant expression of m
    Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
    Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of aberrant DNA methylation during colorectal cancer development.
    Sakai E; Nakajima A; Kaneda A
    World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide methylation and expression profiling identify methylation-associated genes in colorectal cancer.
    Sun X; Chen D; Jin Z; Chen T; Lin A; Jin H; Zhu Y; Lai M
    Epigenomics; 2020 Jan; 12(1):19-36. PubMed ID: 31833403
    [No Abstract]   [Full Text] [Related]  

  • 31. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.
    Szmida E; Karpiński P; Leszczynski P; Sedziak T; Kielan W; Ostasiewicz P; Sasiadek MM
    J Appl Genet; 2015 May; 56(2):185-92. PubMed ID: 25366420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter Methylation Status of Two Novel Human Genes, UBE2Q1 and UBE2Q2, in Colorectal Cancer: a New Finding in Iranian Patients.
    Mokarram P; Shakiba-Jam F; Kavousipour S; Sarabi MM; Seghatoleslam A
    Asian Pac J Cancer Prev; 2015; 16(18):8247-52. PubMed ID: 26745068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer.
    Zhu Q; Jin Z; Yuan Y; Lu Q; Ge D; Zong M
    Scand J Gastroenterol; 2011 Apr; 46(4):436-45. PubMed ID: 21128871
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Ansar M; Wang CJ; Wang YH; Shen TH; Hung CS; Chang SC; Lin RK
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.
    Sugimachi K; Matsumura T; Shimamura T; Hirata H; Uchi R; Ueda M; Sakimura S; Iguchi T; Eguchi H; Masuda T; Morita K; Takenaka K; Maehara Y; Mori M; Mimori K
    Ann Surg Oncol; 2016 Nov; 23(12):3948-3955. PubMed ID: 27271927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of quantifying
    Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
    Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
    Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
    J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A
    Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.